Literature DB >> 8399320

A beneficial role of bile pigments as an endogenous tissue protector: anti-complement effects of biliverdin and conjugated bilirubin.

T Nakagami1, K Toyomura, T Kinoshita, S Morisawa.   

Abstract

Bile pigments possess an anti-complement property and could be involved in tissue protection. In this study, we examined the physiological actions of bile pigments, which had been generally regarded as waste catabolites. Biliverdin inhibited complement cascade reactions in vitro, especially at the C1 step in the classical pathway at low micromolar concentrations. Further, Forssman anaphylaxis in guinea pigs, being closely associated with complement reactions, was inhibited by oral or intravenous administration of biliverdin. Conjugated bilirubin also showed an inhibitory effect on complement-dependent reactions in vitro. From these observations, we propose a hypothesis that the pigments serve as endogenous tissue protectors by multiple lines of mechanisms including antioxidant and anti-complement actions.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8399320     DOI: 10.1016/0304-4165(93)90013-x

Source DB:  PubMed          Journal:  Biochim Biophys Acta        ISSN: 0006-3002


  59 in total

1.  The jaundice of the cell.

Authors:  David A Greenberg
Journal:  Proc Natl Acad Sci U S A       Date:  2002-12-02       Impact factor: 11.205

Review 2.  Elevated bilirubin levels and risk of developing chronic kidney disease: a dose-response meta-analysis and systematic review of cohort studies.

Authors:  Jun Wang; Peng Guo; ZhengYan Gao; BenGang Zhou; Lei Ren; Yu Chen; Quan Zhou
Journal:  Int Urol Nephrol       Date:  2017-08-14       Impact factor: 2.370

3.  Serum bilirubin level and its impact on the progression of chronic kidney disease.

Authors:  Koray Uludag; Nilufer Oguzhan; Tamer Arıkan; Gulsah Boz
Journal:  Int Urol Nephrol       Date:  2018-06-26       Impact factor: 2.370

4.  Serum bilirubin levels in familial hypercholesterolemia: a new risk marker for cardiovascular disease?

Authors:  Pernette R W de Sauvage Nolting; D Meeike Kusters; Barbara A Hutten; John J P Kastelein
Journal:  J Lipid Res       Date:  2011-06-23       Impact factor: 5.922

5.  Microarray analysis of murine retinal light damage reveals changes in iron regulatory, complement, and antioxidant genes in the neurosensory retina and isolated RPE.

Authors:  Majda Hadziahmetovic; Usha Kumar; Ying Song; Steven Grieco; Delu Song; Yafeng Li; John W Tobias; Joshua L Dunaief
Journal:  Invest Ophthalmol Vis Sci       Date:  2012-08-07       Impact factor: 4.799

6.  Bile pigment pharmacokinetics and absorption in the rat: therapeutic potential for enteral administration.

Authors:  A C Bulmer; J S Coombes; J T Blanchfield; I Toth; R G Fassett; S M Taylor
Journal:  Br J Pharmacol       Date:  2011-12       Impact factor: 8.739

7.  Upregulation of heme oxygenase-1 protects genetically fat Zucker rat livers from ischemia/reperfusion injury.

Authors:  F Amersi; R Buelow; H Kato; B Ke; A J Coito; X D Shen; D Zhao; J Zaky; J Melinek; C R Lassman; J K Kolls; J Alam; T Ritter; H D Volk; D G Farmer; R M Ghobrial; R W Busuttil; J W Kupiec-Weglinski
Journal:  J Clin Invest       Date:  1999-12       Impact factor: 14.808

8.  Inhibition of secretory phospholipase A(2) enzyme by bilirubin: a new role as endogenous anti-inflammatory molecule.

Authors:  Noor Mohamed Jameel; Brigitte M Frey; Felix J Frey; T Veerabasappa Gowda; Bannikuppe S Vishwanath
Journal:  Mol Cell Biochem       Date:  2005-08       Impact factor: 3.396

9.  Relationship between serum bilirubin concentration and nondipper hypertension.

Authors:  Mehmet Demir; Canan Demir; Serdar Keçeoğlu
Journal:  Int J Clin Exp Med       Date:  2014-05-15

10.  The heme oxygenase-1 genotype is a risk factor to renal impairment of IgA nephropathy at diagnosis, which is a strong predictor of mortality.

Authors:  Ho Jun Chin; Hyun Jin Cho; Tae Woo Lee; Ki Young Na; Hyung Jin Yoon; Dong-Wan Chae; Suhnggwon Kim; Un Sil Jeon; Jun-Young Do; Jong-Won Park; Kyung-Woo Yoon; Young-Tai Shin; Kang Wook Lee; Ki-Ryang Na; Dae Ryong Cha; Young Sun Kang
Journal:  J Korean Med Sci       Date:  2009-01-28       Impact factor: 2.153

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.